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Abstract
Background: Cardiovascular damages poses risks to children with Kawasaki disease (KD). Although
hypertriglyceridemia and hypercholesteremia are risk factors of cardiovascular damages, studies on the blood lipid
metabolism in KD are still limited. This study aims to analyze the blood lipids and coagulation in KD.
Methods: Triglyceride (TG) and cholesterol levels in the plasma and serum from 20 children with KD were examined in
comparison with 10 healthy children (HC) as well as 10 children with high fever from identified bacterial infections (BT).
Using electrospray ionization mass spectrometry, we profiled the lipid species. Blood coagulation was analyzed.
Statistics was analyzed by one-way ANOVA using SigmaStat.
Results: We found that in KD, plasma TG level was significantly increased, but not serum TG. A total of 19 molecular
species of TG were identified, and they were all increased in KD and BT patients, and more pronounced in KD. On the
other hand, major molecular species of plasma phosphotidylcholine and lyso-phosphotidylcholine were decreased in
KD and BT. Pronounced hypercoagulation was found in KD blood.
Conclusion: Our data indicate hyperlipidemia in KD, especially for TG, which contributes to the hypercoagulation and
the potential risk of cardiovascular damages. Evaluation of blood lipid levels in severe KD patients could
provide valuable information for treatment and prognosis, thus would be worthy of consideration.
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Background
First described by T. Kawasaki [1], Kawasaki disease
(KD) is a systematic syndrome with unknown etiology. It
broadly affects blood vessels, skin, mucous and lymph
nodes, and is typically manifested by fever and systemic
vasculitis, and poses risk to patients’ life when the cor-
onary arteries are affected. KD is most common in chil-
dren under 5 years of age, males and of Asian ethnicity.
It is attributed to immune disease since KD vaculitis is
accompanied by increase of inflammatory cells and cyto-
kines without identified pathogens, and is responsive to
intravenous immunoglobulin and corticosteroid therapy.
In our provincial children’s hospital in Zhejiang, China,
about 350 KD patients are admitted each year and 5-6 %
are accompanied by coronary artery lesions, while severe
cardiovascular damages including and valvular insuffi-
ciencies and cardiogenic shock are rare complications
[2]. Intravenous immunoglobulin is our first line therapy
with the responsive rate of 85 %, yet the risk to de-
velop cardiovascular damages is increased in intraven-
ous immunoglobulin-resistant patients. The recovered
KD patients have a higher risk to develop atherosclerosis
in adult years [3–6].
Although the accompanying and secondary cardiovascu-
lar damages pose great risk to KD children, studies on the
blood lipid metabolism in KD are still limited. Biolipids are
not only compositional materials as compartmental barrier,
but also signaling molecules that mediates cellular func-
tions. Lipid metabolites are currently used as biomarkers
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for the diagnosis and prognosis of cardiovascular diseases,
cancer, and neurological diseases. In recent years, tandem
mass spectrometric technique has greatly facilitated the
quantitative and qualitative studies of biolipids, and lipido-
mics analysis is currently being expanded as a diagnostic
tool for the benefit of personalized medicine [7]. The blood
contains thousands of biolipid species, the levels are deter-
mined by both food intake and acquired or secondary
factors including individual genetics and metabolic traits.
In this study, we analyzed the blood lipid profile in KD
children in comparison with healthy children (HC) and
children with high fever (>38 °C) from diagnosed bacterial
infections (BT) from the same age group by biochemical
methods as well as electrospray ionization mass spec-
trometry (ESI MS).
Blood triglyceride (TG) is distributed between chylo-
microns and very-low density lipoprotein. It has been
recognized that hypertriglyceridemia is a risk factor of
cardiovascular damages independent of cholesterol [8–12].
Our study has analyzed the specific change of TG molecu-
lar species as it is the major component of blood lipids.
There is a potential link established between increased
blood TG and low-grade inflammation [10, 12] that is
also manifested in KD patients.
Results
Hypercoagulation in KD patients
KD patients were diagnosed based on symptoms [1, 13].
On the day when fasting blood samples were collected,
the patients were still feverish, with C-reaction protein
(CRP) and erythrocyte sedimentation rate (ESR) signifi-
cantly exceeding the normal range (Table 1), suggesting
persisted inflammation.
From Fig. 1a, the platelet number was 349 ± 169 × 10^9/L
in the KD group, and 276 ± 39 × 10^9/L in the group
of healthy controls (HC). The fibrinogen level was
4.88 ± 0.71 g/L in the KD group, and was 2.04 ± 0.48 g/L
in the HC group. The level of D-dimer was 1.55 ±
1.74 mg/L in the KD group, and was 0.48 ± 0.52 mg/L in
the HC group. The statistical differences were signifi-
cant (P < 0.05). Prothrombin time (PT), activated par-
tial thromboplastin time (APTT) and thrombin time
(TT) were all within the normal range and showed
no significant differences between all sample groups
(Additional file 1: Table S1).
Thromroelastography (TEG) monitors the process of
blood clot formation and retraction dynamically. It was
first established by Harter in 1948, and has been proved
valuable in examining coagulation specifically [14, 15].
Our facility produces the following parameters of signifi-
cance: R (reaction time) stands for the time for initial
fibrin formation, and prolongation of R value is due
to coagulation factor deficiencies; K (coagulation time)
measures the speed of clot strengthening, and increased K
value suggests hypofibrogenemia or platelet dysfunction;
the maximum amplitude (MA) represents the clot strength,
and is a parameter to judge platelet function; the coagula-
tion index (CI) is a parameter for the overall coagulation
state. We examined 20 KD blood samples by TEG, and the
results have revealed marked hypercoagulation. Typical
thromboelastographs from a healthy individual and that
from a KD patient are shown (Fig. 1b, c). As summarized
in Table 2, in the KD patients, the R value was significantly
lowered (4.3 ± 1.8 compared with 5-10), the K value was
within the normal range, MA was significantly increased
(75.9 ± 4.6 compared with 50-70), and so was CI (3.9 ± 1.8
compared with -3- + 3). As judged by CI, the occurrence
rate of hypercoagulation in KD was 80 %. Most of the KD
patients had abnormal MA (95 %) and R (80 %) values,
while only 15 % had abnormal K.
Increased plasma TG, but not serum TG in KD
Both plasma and serum are being used for blood lipid
testing. From the literature, the plasma is considered to be
more optimal to reflect the original physiological proper-
ties compared with the serum [16]. TG and cholesterol
levels from serum and plasma were both examined. As
shown in Fig. 2, total plasmaTG was significantly increased
Table 1 Summarized clinical information of the 20 patients with
Kawasaki disease recruited in our study on the day of blood
sample colllection
Age Sex Days of fever Body temp, °C CRPa ESRb
1 4y9m M 3 38.8 83 66
2 5y1m F 5 38.5 94 64
3 4m23d M 5 36.8 110 62
4 5y6m F 7 36.8 >160 75
5 8m13d M 8 39.0 23 76
6 3y10m F 5 38.5 128 93
7 2y9m M 5 39.5 63 66
8 1y1m M 5 38.0 139 66
9 3y11m F 5 39.1 98 88
10 5y2m M 5 38.5 41 55
11 1y8m M 6 39.5 69 55
12 1y6m F 6 38.9 >160 57
13 1y10m M 3 37.2 65 40
14 1y5m M 5 40.5 20 35
15 2y F 3 39.1 >160 73
16 5y4m M 4 38.8 95 75
17 6m17d M 3 39.0 25 83
18 1y5m M 4 38.5 40 62
19 1y2m F 3 38.8 45 87
20 3m22d M 4 39.0 29 66
aC-reaction protein (CRP), normal range 0-8 mg/L
berythrocyte sedimentation rate (ESR), normal range 0-20 mm/h
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in KD compared with the group of HC and the feverish
children with bacterial infections (BT). Levels of plasma
TG in BT and HC groups were not statistically significant.
However, examination of the serum revealed a different
scenario. The TG levels in the HC and KD groups were
not statistically significant, while it was significantly de-
creased in BT patients. Cholesterol levels were similar in
all 3 groups, both in the plasma and the serum.
Plasma TG profiling by mass spectrometry
Our established high performance liquid chromatography-
electrospray ionization- quadrupole time of flight mass
spectrometry (HPLC-ESI-QTOF MS)-based protocol scans
over 20,000 molecular species of polar lipids. All lipids were
eluted from the HSS T3 column within 12 min of elution
(Fig. 3a), lyso-phosphatidylcholine (LPC) species were
eluted at the first 2 min, phosphatidylcholine (PC) species
were eluted from 2 to 6 min, while TGs were eluted from 6
to 10 min. By performing partial least square-discriminant
analysis, the 3 experimental groups were well separated
(Fig. 3b) and lipid species contributing to the discriminative
separation were picked and confirmed by LIPID MAPS.
Besides the neutral lipid cholesterol, the major plasma
lipid is TG and PC. Consistently, we found these two
classes were the major contributing species to discriminate
the separation between the 3 groups.
From the most abundant 100 molecular species of
plasma polar lipids, 19 was identified as TGs, which
were all significantly increased in KD as well as BT pa-
tients (Fig. 4 and Additional file 1: Table S2). From the
19 TGs, 5 species were significantly increased in KD
compared with the BT group: TG 48:1, TG 52:1, TG,
52:3, TG 52:4 and TG 56:8. These are the relatively more
abundant TGs, consisting 41 % of total TG in KD, and
36-37 % in HC and BT groups.
Decrease of plasma PC and LPC in KD patients
PC is the second abundant group of polar plasma lipids.
In our study, we have observed significant changes in
several PC molecular species from KD and BT groups
compared with controls, including 7 PCs and 2 LPCs.
Contrary from TG, PC and LPC species were decreased
in patients (Fig. 5 and Additional file 1: Table S3). Of the
7 PCs of interest, 2 molecular species with relatively
shorter free fatty acid (FFA) chains, PC 14:0/18:1 and PC
14:0/20:2, were more significantly decreased in KD, while
the other 5 were more significantly decreased in BT. How-
ever, change of PC profile was not significant between KD
and BTgroups. Change of the two LPCs was more striking
than PC, significantly decreased in KD and even further
decreased in BT (Fig. 5 and Additional file 1: Table S3). It
Fig. 1 Blood coagulation and thromboelastography analysis. a Comparison of platelet number, plasma fibrinogen (g/L) and D-dimer (mg/L) levels
from healthy children (HC) and Kawasaki disease (KD). *: P < 0.05. **: P < 0.01. b-c Representative thromboelastographs from blood samples with
normal coagulation (b) and with hypercoagulative state in a patient with Kawasaki disease (c)
Table 2 Collected parameters by thromboelastography analysis
of blood samples from 20 patients with Kawasaki disease
R K MA CI
Mean 4.3 1.2 75.9 3.9
SD 1.8 0.3 4.6 1.8
Reference range 5—10 1—3 50—70 -3—3
Abnormal rate 80.0 % 15.0 % 95.0 % 80.0 %
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was possible to separate KD and BT by the LPC content
because of the extremely sharp decrease of LPC in BT
patients.
Discussion
Hypercoagulation in KD and anti-coagulation therapy
Platelet counting and coagulation analysis revealed sig-
nificant increase of plate number and levels of fibrinogen
and D-dimer in KD (Fig. 1a), suggesting hypercoagulation
as a common complication of KD patients. As a point-of-
care testing method, TEG monitors the dynamic formation
of blood clots, and is advantageous than traditional meas-
urement of coagulation factors in its fast testing speed and
the ability to further discriminate between platelet- and
fibrinogen-associated coagulation. Although no increase of
prothrombin time, activated partial thromboplastin time
and thrombin time was detected, TEG indicates that blood
coagulation was faster in 80 % KD patients (Table 2).
Change in MA that represents platelet dysfunction was
manifested in 95 % of KD patients, while the K value
associated with fibrinogen was mostly within the nor-
mal range. Based on our data and previous clinical
experience, increased fibrinogen level does not necessarily
lead to significant fastened blood coagulation. Fibrinogen is
an acute-phase protein produced in the liver upon stimula-
tion of a broad spectrum of stress signals including
Fig. 2 Serum and plasma triglyceride and cholesterol levels. Blood biochemistry analysis of plasma and serum triglyceride (TG) and cholesterol (chol) levels
from 3 groups: healthy children (CL), patients from diagnosed bacterial infections (BT) and patients with Kawasaki disease (KD). *P: <0.05
Fig. 3 Detection of polar lipids by UPLC-ESI-MS and discriminant analysis between groups. a Total ion current of representative plasma lipid extract from
UPLC-ESI-QTOF MS. Within the 12 min of elution time of each sample, lyso-phosphatidylcholine (LPC), phosphatidylcholine (PC) and sphingomyelin (SM)
were eluted serially, followed by triglyceride (TG). b The PLS-DA scoring chart by EZ info software of plasma lipids detected by the positive ESI mode MS
from three groups (HC: control; BT: feverish with bacterial infections; KD: Kawasaki disease) indicates separation of sample groups
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inflammation, trauma, etc. Compared with the fibrinogen
level, activation of platelet is a more significant contribut-
ing factor of fastened blood coagulation. Both PT/APTT
and TEG analysis suggested that hypercoagulation in KD
patients was mainly attributed to platelet over-activation,
although hyperfibrinogenemia was also involved.
Previous retrospective research identified secondary
thrombocytopenia as a complication in some KD patients
[17, 18], and is a risk factor for severe cardiovascular dam-
ages including coronary artery aneurysm and acute myo-
cardial infarction [19, 20]. These studies also suggested
that thrombocytopenia in KD was a result of intravascular
Fig. 4 Plasma triglyceride profiling and quantification. Profiling and quantification of triglyceride (TG) molecular species from the plasma of healthy
children (HC), children with fever from bacterial infections (BT) and Kawasaki disease (KD). Y axis indicates the area after normalization from Q-TOF MS,
a relative quantification instead of direct measurements of the absolute quantity. Data are presented as mean values, SD and P values are presented in
Additional file 1: Table S2
Fig. 5 Profiling and quantification of plasma phosphatidylcholine and lyso- phosphatidylcholine. Profiling and quantification of major phosphatidylcholine
(PC) and lyso- phosphatidylcholine (LPC) molecular species from the plasma of healthy children (HC), children with fever from bacterial infections (BT) and
Kawasaki disease (KD). The Y axis indicates the area after normalization from Q-TOF MS. Data are presented as mean values, SD and P values are presented
in Additional file 1: Table S3
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coagulation [20]. Furthermore, although not occurred in
our hospital, literature reported a couple of KD cases with
a rare but highly dangerous complication: disseminated
intravascular coagulation (DIC), the dysregulated balance
between coagulation and fibrinolysis [21, 22]. DIC could
occur in KD patients without evidence of pathogen inva-
sion. Based on our findings and the literature, we advise
the clinicians to be cautious with the hypercoagulative
state in KD patients, especially for the severe and intra-
venous immunoglobulin-resistant cases to prevent serious
complications. Guided anti-coagulation therapy could be
of benefit to patients with positive laboratory findings and
other risk factors.
Abnormal plasma TG in KD children
We have examined the levels of TG and cholesterol
from both serum and plasma, and found plasma TG
levels were significantly increased in KD compared with
HC and BT groups, while there was no difference in the
cholesterol levels (Fig. 2). TG is the major component of
very-low density lipoprotein and chylomicrons, while
cholesterol is mainly transported in low density lipopro-
tein. Cholesterol and low density lipoprotein are long
considered as a risk factor for cardiovascular damages,
but the pathological role of TG and very-low density
lipoprotein in cardiovascular damages has only been re-
vealed in recent years. TG hydrolysis in arterial wall
foam cells could lead to development of atherosclerosis
plaques [11]. Lipolysis of TG-rich lipoproteins produces
potentially toxic oxidized FFAs, monoacylglycerols and
other molecules to activate immune cells and stimulate
the production of cytokines along the artery wall [23, 24].
Genome-wide association studies also suggested causal as-
sociation between elevated TG and cardiovascular dam-
ages [25, 26]. Thus increased blood TG levels could
exacerbate inflammation and arterial damage. Our data
suggested that plasma TG metabolism is a more sensitive
parameter than cholesterol in the sterile inflammation
of KD compared with bacteria-induced infection. Such
lipid metabolic change partly explains why KD patients
have extremely high risks to develop cardiovascular dam-
ages such as arteriosclerosis. Consistently, in recent publi-
cations, increase of serum TG (plasma not examined) in
late stage KD was discovered [27], and use of statins was
shown to benefit KD patients to reduce the inflammation
and the endothelial function [28]. In current clinical prac-
tice, both plasma and serum are used to perform blood
lipid analysis. Although there is still no general guidance in
discriminating the two categories of samples in blood lipid
testing, our data suggest that blood coagulation may affect
the lipid profile, such as TG, thus plasma could be a more
reliable object as other researchers have reported [16].
During our study, we found that the TG levels were
clinically reported normal in all patients, however, our
comparative analysis revealed statistic difference be-
tween HC, KD and BT children. This is watchful that
the current blood lipid reference range in pediatric la-
boratory medicine may not be suitable, at least not for
the Chinese children under 5 years of age targeted by
our research. In detail, our currently applied upper value
for plasma cholesterol is 4.4 mM, and is 1.5 mM for TG,
lower than the standards applied for adults (5.2 mM
for cholesterol and 1.7 mM for TG). Our clinical ref-
erence range (plasma cholesterol < = 4.4 mM, plasma
TG < = 1.5 mM) is slightly lower than that applied in
adults, either comparable [29] or not comparable [30, 31]
with data obtained from same age group of children from
other countries. Considering that study on the epidemi-
ology of hypertriglyceridemia in Chinese children is still
very limited in number, we advice re-evaluation of the
current standards by further larger-scale analysis to better
discriminate the healthy and diseased states in blood lipid
metabolism during childhood.
Profiling of plasma TG molecular species in Chinese
children by ESI MS lipidomics analysis
Instead of exhaustive identification of all lipids as some
researchers [32, 33], we selected the lipid species con-
tributing to the difference between the three sample
groups from the top 100 abundant species. 19 TG spe-
cies were the most abundant in prevalence and the most
significant contributing components to differentiate the
3 sample groups (Fig. 4). All the 19 TG species were in-
creased in KD and BT patients, and more significantly in
KD, further supporting the increase of the absolute TG
level in the diseased conditions and a general malregula-
tion of TG metabolism. From our data, in Chinese
children under 5 years of age, the most dominating TG
species were TG 48:2, TG 52:1, TG 50:3, TG 52:2, TG
52:3, TG 50:1 and TG 48:1, contributing to over 70 % of
total TG (Additional file 1: Table S1). Palmatic acid
(16:0) and oleic acid (18:1) were the most common FFA
chains in identified TGs, and the average total carbon
number was under 54. This is less variable and much lon-
ger than the reported result based on the elder western
populations [16, 34]. The FFA composition is determined
by both diets and the metabolic mechanisms, both should
contribute to the difference between our target population
and others’.
In 2014, several reports were published based on a
large Cohort study named San Antonio Family Heart
Study covering over 1200 adult Mexican Americans.
Plasma lipid composition was found to be inheritable
and associated with risk of cardiovascular damages [35, 36].
In these studies, 43 TG molecular species were identified
by ESI MS, and the statistical distribution of various
species was associated with age, sex and body mass
index [37]. In another recent study with the intention to
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identify lipid biomarkers for cardiovascular damages
[34], shotgun lipidomics detected 135 lipid species,
among which TG 54:2 has been found to be a risk
factor. Certain species of TG were attributed to child-
hood obesity [38] and insulin resistance [39]. Our
analysis of molecular species of TG in the blood suggest
metabolic disorder of TG in both bacteria-induced and
sterile inflammation, especially the latter. Further enlarged
samples may be helpful to identify whether it is a risk fac-
tors for KD-associated cardiovascular damages. Discovery
of novel lipid biomarkers will facilitate diagnosis of severe
complications of KD, and to discover more therapeutic
targets in the future.
Besides increase of TG, we also found marked de-
crease of PC and LPC in patients. Unlike TG, change of
PC and LPC was more pronounced in the fever group
caused by bacteria infection (Fig. 5). Our fever group is
composed of children with pneumonia, and in our hos-
pital, such cases are mostly caused by S. pneumoniae,
other pathogens include haemophilus influenzae, myco-
plasma pneumoniae and Klebsiella pneumoniae (inter-
communications). The underlying mechanism of TG
and PC/LPC malregulation remains to be discovered. In
KD patients, blood cytokines levels including IL-1, IL-6,
IL-10, TNFα, and BTNγ were significantly increased
[40, 41]. There was laboratory evidence showing TNFα,
IL-1 and other cytokines could induce TG synthesis
[42–44], meanwhile, association of cytokine patterns
with TG levels have been observed in human [45, 46].
Research on the regulation of inflammatory factors on
lipid metabolism will be informative. Based on previous
literature reports, PPARγ was increased in KD and could
be a potential anti-inflammatory candidate target for
cardiovascular damages in KD cases [47]. It remains
to be confirmed if PPARγ could serve as a promising
therapeutic target for KD.
In summary, our research has identified pro-
nounced change in plasma TG, PC and LPC in KD
patients with detailed profiling of molecular species.
Increase of blood TG, together with hypercoagulation
in KD imply the necessity to control blood lipid
levels as well as anti-coagulation therapy, such as use
of statins.
Conclusions
Our study demonstrated hyperlipidemia in KD chil-
dren, especially for TG species, which contributes to
hypercoagulation and the potential risk of cardiovas-
cular damages, thus would be worthy of further
evaluation in severe KD patients to provide informa-
tion to guide treatment and prognosis. Meanwhile,
our data suggested malregulation of blood lipid me-




This study was approved by the ethics committee of the
Children’s Hospital, Zhejiang University School of Medi-
cine. The study protocol conforms to the ethics guide-
lines of the 1975 Declaration of Helsinki, as was
reflected in the a priori approval provided by the institu-
tion’s human research committee. Informed consent was
obtained from each patient’s parent or guardian.
Fasting blood samples were collected from 20 KD pa-
tients, 10 patients of bacterial pneumonia with body
temperature above 38 °C (bacterial infection group, BT),
and 10 healthy children for routine body examination
(healthy control group, HC). All patients were admitted
to the hospital ward from June to October, 2013. The
KD patients were 13 boys and 7 girls aged between
4-month to 5-year-6-month, the median age was 2-
year-9-month. At the time of blood collection, all KD
patients were in the acute stage with fever above 37 °C for
over 3 days and without intravenous immunoglobulin
administration, which was proved to be effective to all
cases in the later treatments. The clinical information of
KD patients is summarized in Table 1.
Processing of blood samples, blood biochemistry and
thromboelastography analysis
Serum samples were subjected to laboratory test for CRP,
ESR, TG/cholesterol levels and other parameters by an
automatic biochemistry analyzer (DPP modular, Roche,
USA). Blood samples with the presence of sodium citrate
as anti-coagulant were analyzed by an automatic blood
analyzer (Mindray BC-5300, China) for the platelet number,
etc. Levels of fibrinogen and D-dimer were analyzed by a
full-automatic coagulation analyzer (Sysmex CA1500, Japan).
Thromroelastography (TEG) was collected from a
TEG5000 Haemoscope (Niles, USA), with sodium citrate
as anti-coagulant and kaolin as coagulation initiator. In
TEG analysis, 1 mL whole blood is placed in a rotating
metal cuvette heated to 37 °C, as fibrin strands form be-
tween the wall of the cuvette and a piston suspended in
the sample, the rotational motion gets transferred to
the piston, and an electronic amplification system al-
lows the characteristic tracing to be recorded.
Blood samples with anti-coagulant were spun at 3000 rpm
for 10 min, supernatants (plasma) were aliquoted into sili-
conized eppendorf tubes (SafeSeal, PGC Scientifics, USA),
frozen in dry ice and stored at -80 °C until use for lipid ex-
traction and measurement of plasma TG/cholesterol.
Mass spectrometry analysis of lipids extracted from plasma
HPLC-grade acetonitrile, isopropanol, formic acid and
ammonium formate were purchased from Sigma or
Fisher Scientific (USA). Ultrapure water from Milli-Q
purification system (Millipore, USA) was used.
Chen et al. Lipids in Health and Disease  (2015) 14:166 Page 7 of 9
Plasma lipids were extracted by isopropanol [48]. In
brief, 10 μL of plasma was mixed with 500 μL of isopro-
panol, after vortexing and centrifugation (10,000 × g,
5 min, room temperature), the supernatant was retained
and 2 μL of which was loaded into mass spectrometer
with an auto sampler through a LC system (UPLC H-
class, Waters, USA). A HSS T3 column (1.8 μm, 2.1 mm
ID × 100 mm, Waters, USA) maintained at 65 °C was
used for separation of lipids. The mobile phase A was
isopropanol/acetonitrile/formic acid (90:10:0.1, v/v/v)
containing 10 mM ammonium formate; the mobile phase
B was acetonitrile/water/formic acid (60:40:0.1, v/v/v) con-
taining 10 mM ammonium formate. The UPLC separa-
tions were 12 min/sample using the following scheme: 1)
0 min, 60 % B; 2) 10 min, 1 % B; 3) 12 min, 60 % B. All
changes were linear with a flow rate of 400 μL/min.
Lipid profile analysis was performed using ESI Q-TOF
MS (Xevo G2, Waters, USA). Both the nebulizer and
desolvation gases were nitrogen. Typical operating con-
dition was set as follows: capillary voltage 3.0 kV, sam-
pling cone voltage 40 V, desolvation gas temperature
500 °C, source temperature 150 °C, nebulization gas flow
40 L/h, and desolvation gas flow 400 L/h. The m/z range
detected was from 50 to 1200. The positive ion MSE
mode was used for data acquisition.
Statistical analysis
Data obtained by MS were processed by Markerlynx XS
and EZ info softwares (Waters, USA). Markerlynx XS
was used to carry out peak discrimination, filtering, and
retention time alignment, yielding >20000 peaks between
the retention time of 0–12 min. To investigate global
lipids alterations, all observations acquired were integrated
and co-analyzed using partial least square-discriminant
analysis by EZ info software. The VIP-plot in EZ info soft-
ware was further carried out to select variables as potential
markers for distinguishing patients from controls. The VIP
value reflects the influence of every variable on the classifi-
cation, and is considered to have above-average influence
when higher than 1.0. In our work, the variables with a VIP
value of >4.0 were highlighted and selected. Their accurate
m/z information was used to search the matched lipid from
database established by Waters or from LIPID MAPS
(http://www.lipidmaps.org). The fragment ions were further
utilized for confirmation of the marker. Significance of dif-
ference between multiple groups were analyzed by one-way
ANOVA by SigmaStat (v3.5), and P <0.05 were considered
statistically significant.
Additional file
Additional file 1: Table S1. Blood coagulation analysis of prothrombin
time (PT), activated partial thromboplastin time (APTT) and thrombin
time (TT) from healthy children (HC) and Kawasaki disease (KD). Data are
presented as mean±SD. Table S2. Detailed quantitative data and the
statistical analysis of 19 TG molecular species contributing to the difference
between the three groups. HC: healthy children; BT: fever patients from
bacterial infections; KD: Kawasaki disease. Table S3. Detailed quantitative
data and the statistical analysis of PC and LPC molecular species contributing
to the difference between the three groups. HC: healthy children; BT: fever
patients from bacterial infections; KD: Kawasaki disease. (DOCX 33 kb)
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APTT: activated partial thromboplastin time; BT: children with bacterial
infections; BTNγ: butyrophilin γ; CRP: C-reaction protein; DIC: disseminated
intravascular coagulation; ESI: electrospray ionization; ESR: erythrocyte
sedimentation rate; FFA: free fatty acid; HC: healthy children; HPLC: high
performance liquid chromatography; IL: interleukin; KD: Kawasaki disease;
LPC: lyso-phosphatidylcholine; MS: mass spectrometry; PC: phosphatidylcholine);
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